意想不到的胜利:具有远程转移的高风险乳头甲状腺癌对第一个RAI治疗表现出了非凡的反应
Muntaha Fatima Rana1, Fatima Ibrahim1, Aamna Hassan1
1Department of Nuclear Medicine, Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan.
JPMA. The Journal of the Pakistan Medical Association
|December 11, 2024
概括
乳头甲状腺癌 (PTC) 是最常见的甲状腺癌,在全球范围内正在增加. 这项案例研究突出显示,在患有转移性PTC的高风险患者中,对放射性治疗的良好反应.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 核医学就是核医学.
背景情况:
- 乳头甲状腺癌 (PTC) 是最常见的分化甲状腺癌类型.
- 全球PTC发病率正在上升,尽管死亡率普遍较低.
- 治疗包括手术和放射性治疗,并进行持续监测.
研究的目的:
- 为了呈现一个高风险的乳头甲状腺癌病例与肺转移.
- 为了证明放射性治疗在这种情况下的有效性.
主要方法:
- 案例报告的呈现方式.
- 对高风险PTC的治疗方案的审查.
- 评估患者对放射性治疗的反应.
主要成果:
- 该患者患有高风险的肺转移性PTC.
- 在最初的放射性治疗后,观察到出色的反应.
- 这表明放射性治疗在侵袭性PTC中的有效性.
结论:
- 放射性疗法即使在侵袭性,转移性乳头甲状腺癌的情况下也可以非常有效.
- 早期和有效的治疗对于管理高风险PTC至关重要.
- 这一案例强调了针对差异化甲状腺癌量身定制的治疗策略的重要性.
关键词:
甲状腺癌,肺转移,反应很好.
相关概念视频
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...